LifeTech Scientific's book value per share for the quarter that ended in Dec. 2023 was HK$0.80.
During the past 12 months, LifeTech Scientific's average Book Value Per Share Growth Rate was 13.70% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was 9.90% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was 22.70% per year.
During the past 10 years, the average Book Value Per Share Growth Rate was 34.00% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the book value growth rate using book value per share data.
During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of LifeTech Scientific was 83.00% per year. The lowest was -16.60% per year. And the median was 27.25% per year.
During the past 13 years, the highest P/B Ratio of LifeTech Scientific was 54.47. The lowest was 2.00. And the median was 7.42.
Good Sign:
LifeTech Scientific Corp stock PB Ratio (=2.04) is close to 10-year low of 2
LifeTech Scientific Book Value per Share Historical Data
The historical data trend for LifeTech Scientific's Book Value per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of LifeTech Scientific's Book Value per Share
For the Medical Devices subindustry, LifeTech Scientific's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
LifeTech Scientific's PB Ratio Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, LifeTech Scientific's PB Ratio distribution charts can be found below:
* The bar in red indicates where LifeTech Scientific's PB Ratio falls into.
LifeTech Scientific Book Value per Share Calculation
LifeTech Scientific's Book Value Per Share for the fiscal year that ended in Dec. 2023 is calculated as:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Book value may include intangible items which may come from the company's past acquisitions. Book value less intangibles is called Tangible Book.
LifeTech Scientific (HKSE:01302) Book Value per Share Explanation
Usually a company's book value and Tangible Book per Share may not reflect its true value. The assets may be carried on the balance sheets at the original cost minus depreciation. This may underestimate the true economic values of the assets. It also may over-estimate their true economic value because the assets can become obsolete.
For financial companies such as banks and insurance companies, their assets may be reported in current market value of the assets owned. Book values of financial companies are more accurate indicator of the economic value of the company.
LifeTech Scientific Book Value per Share Related Terms
Thank you for viewing the detailed overview of LifeTech Scientific's Book Value per Share provided by GuruFocus.com. Please click on the following links to see related term pages.
LifeTech Scientific (HKSE:01302) Business Description
LifeTech Scientific Corp develops and manufactures minimally invasive medical devices for cardiovascular and vascular diseases. The firm operates in three areas: Structural heart diseases business; Peripheral vascular diseases business and Cardiac pacing and electrophysiology business. It generates maximum revenue from the Peripheral vascular diseases business segment. Geographically, it derives a majority of revenue from China.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
HKSE:01302 has been successfully added to your 